Civetta Therapeutics, LLC, a biotechnology company focused on developing a pipeline of therapies that target beta-propeller proteins, today announced that Christopher D. Roberts, Ph.D., has been appointed as Chief Executive Officer.
September 2, 2021
· 3 min read